Clinical trials
Obesity trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
88 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 7 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Recruiting | 13 |
| Unknown status | 10 |
| Active, not recruiting | 7 |
| Terminated | 5 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Turku University Hospital | 15 |
| Sanofi | 10 |
| Novo Nordisk A/S | 9 |
| University of Eastern Finland | 8 |
| University of Oulu | 6 |
| University of Turku | 5 |
| Boehringer Ingelheim | 4 |
| Helsinki University Central Hospital | 4 |
| Amgen | 3 |
| Finnish Institute for Health and Welfare | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 88 |
| Overweight | 28 |
| Diabetes Mellitus, Type 2 | 12 |
| Insulin Resistance | 8 |
| Cardiovascular Diseases | 7 |
| Dyslipidemias | 5 |
| Nutrition Disorders | 5 |
| Body Weight | 4 |
| Hypertension | 4 |
| Prediabetic State | 4 |
Trials
Showing 26 to 50 of 88. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.